Holly Walton

Holly Walton

Auto-generated profile, based on publicly available information

Holly Walton

Department of Behavioural Science and Health, Institute of Epidemiology and Healthcare, University College London, London, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in British Journal of Health Psychology
Verified
Journal Article
Open access
PDF file
HWHolly Walton
Holly Walton
ASAimee Spector
Aimee Spector
ITIldiko Tombor
Ildiko Tombor
SMSusan Michie
Susan Michie
Purpose: Understanding the effectiveness of complex, face‐to‐face health behaviour change interventions requires high‐quality measures to assess fidelity of delivery and engagement. This systematic review aimed to (1) identify the types of measures used to monitor fidelity of delivery of, and engagement with, complex, face‐to‐face health behaviour change interventions and (2) describe the reporting of psychometric and implementation qualities. Methods: Electronic databases were searched, systematic reviews and reference lists were hand‐searched, and 21 experts were contacted to identify articles. Studies that quantitatively measured fidelity of delivery of, and/or engagement with, a complex, face‐to‐face health behaviour change intervention for adults were included. Data on interventions, measures, and psychometric and implementation qualities were extracted and synthesized using narrative analysis. Results: Sixty‐six studies were included: 24 measured both fidelity of delivery and engagement, 20 measured fidelity of delivery, and 22 measured engagement. Measures of fidelity of delivery included observation ( n = 17; 38.6%), self‐report ( n = 15; 34%), quantitatively rated qualitative interviews ( n = 1; 2.3%), or multiple measures ( n = 11; 25%). Measures of engagement included self‐report ( n = 18; 39.1%), intervention records ( n = 11; 24%), or multiple measures ( n = 17; 37%). Fifty‐one studies (77%) reported at least one psychometric or implementation quality; 49 studies (74.2%) reported at least one psychometric quality, and 17 studies (25.8%) reported at least one implementation quality. Conclusion: Fewer than half of the reviewed studies measured both fidelity of delivery of, and engagement with complex, face‐to‐face health behaviour change interventions. More studies reported psychometric qualities than implementation qualities. Interpretation of intervention outcomes from fidelity of delivery and engagement measurements may be limited due to a lack of reporting of psychometric and implementation qualities. Statement of contribution: What is already known on this subject? Evidence of fidelity and engagement is needed to understand effectiveness of complex interventions Evidence of fidelity and engagement are rarely reported High‐quality measures are needed to measure fidelity and engagement What does this study add? Evidence that indicators of quality of measures are reported in some studies Evidence that psychometric qualities are reported more frequently than implementation qualities A recommendation for intervention evaluations to report indicators of quality of fidelity and engagement measures

6 November 2019 in British Journal of Health Psychology
Verified
Journal Article
Open access
PDF file
HWHolly Walton
Holly Walton
ASAimee Spector
Aimee Spector
MWMorgan Williamson
Morgan Williamson
ITIldiko Tombor
Ildiko Tombor
SMSusan Michie
Susan Michie
Objectives: To understand whether interventions are effective, we need to know whether the interventions are delivered as planned (with fidelity) and engaged with. To measure fidelity and engagement effectively, high‐quality measures are needed. We outline a five‐step method which can be used to develop quality measures of fidelity and engagement for complex health interventions. We provide examples from a fidelity study conducted within an evaluation of an intervention aimed to increase independence in dementia. Methods: We propose five steps that can be systematically used to develop fidelity checklists for researchers, providers, and participants to measure fidelity and engagement. These steps include the following: (1) reviewing previous measures, (2) analysing intervention components and developing a framework outlining the content of the intervention, (3) developing fidelity checklists and coding guidelines, (4) obtaining feedback about the content and wording of checklists and guidelines, and (5) piloting and refining checklists and coding guidelines to assess and improve reliability. Results: Three fidelity checklists that can be used reliably were developed to measure fidelity of and engagement with, the Promoting Independence in Dementia (PRIDE) intervention. As these measures were designed to be used by researchers, providers, and participants, we developed two versions of the checklists: one for participants and one for researchers and providers. Conclusions: The five steps that we propose can be used to develop psychometrically robust and implementable measures of fidelity and engagement for complex health interventions that can be used by different target audiences. By considering quality when developing measures, we can be more confident in the interpretation of intervention outcomes drawn from fidelity and engagement studies. Statement of contribution: What is already known on the subject? Fidelity and engagement can be measured using a range of methods, such as observation and self‐report. Studies seldom report psychometric and implementation qualities of fidelity measures. What does this study add? A method for developing fidelity and engagement measures for complex health interventions. Guidance on how to consider quality when developing fidelity and engagement measures.

12 May 2025 in eClinicalMedicine
Verified
Journal Article
Open access
RLRachel Lawrence
Rachel Lawrence
EDEmma Dodsworth
Emma Dodsworth
EMEfthalia Massou
Efthalia Massou
CSChris Sherlaw-Johnson
Chris Sherlaw-Johnson
ARAngus I.G. Ramsay
Angus I.G. Ramsay
NFNaomi J. Fulop
Naomi J. Fulop
The aim of this review was to evaluate evidence on the use of Artificial Intelligence (AI) to support diagnostics in radiology, including implementation, experiences, perceptions, quantitative, and cost outcomes. We conducted a systematic scoping review (PROSPERO registration: CRD42024537518) and discussed emerging findings with relevant stakeholders (radiology staff, public members) using workshops. We searched four databases and the grey literature for articles published between 1st January 2020 and 31st January 2025. Articles were screened for eligibility (N = 8013), resulting in 140 included studies. Studies evaluated implementation (N = 7), perceptions (N = 74), experiences (N = 14), effectiveness (N = 53), and cost (N = 6). Factors influencing AI adoption were identified, including the high technical demand, lack of guidance, training/knowledge, transparency, and expert engagement. Evidence demonstrated improvements in diagnostic accuracy and reductions in interpretation time. However, evidence was mixed regarding experiences of using AI, the risk of increasing false positives, and the wider impact of AI on workflow efficiency and cost-effectiveness. The potential benefits of AI are evident, but there is a paucity of evidence in real-world settings, supporting cautiousness in how AI is perceived (e.g., as a complementary tool, not a solution). We outline wider implications for policy and practice and summarise evidence gaps. This project is funded by the 10.13039/501100000272 National Institute for Health and Care Research , 10.13039/501100022224 Health and Social Care Delivery Research programme (Ref: NIHR156380). NJF and AIGR are supported by the 10.13039/501100000272 National Institute for Health Research (NIHR) Central London Patient Safety Research Collaboration and NJF is an NIHR Senior Investigator. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.

10 February 2021 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
ASAmy Simpson
Amy Simpson
LBLara Bloom
Lara Bloom
NFNaomi J. Fulop
Naomi J. Fulop
EHEmma Hudson
Emma Hudson
KLKerry Leeson-Beevers
Kerry Leeson-Beevers
AHAmy Hunter
Amy Hunter
Background: Care coordination is considered important for patients with rare conditions, yet research addressing the impact of care coordination is limited. This study aimed to explore how care coordination (or lack of) impacts on patients and carers. Semi-structured interviews were conducted with 15 patients and carers/parents in the UK, representing a range of rare conditions (including undiagnosed conditions). Transcripts were analysed thematically in an iterative process. Results: Participants described a range of experiences and views in relation to care coordination. Reports of uncoordinated care emerged: appointments were uncoordinated, communication between key stakeholders was ineffective, patients and carers were required to coordinate their own care, and care was not coordinated to meet the changing needs of patients in different scenarios. As a result, participants experienced an additional burden and barriers/delays to accessing care. The impacts described by patients and carers, either attributed to or exacerbated by uncoordinated care, included: impact on physical health (including fatigue), financial impact (including loss of earnings and travel costs), and psychosocial impact (including disruption to school, work and emotional burden). Overall data highlight the importance of flexible care, which meets individual needs throughout patients’/carers’ journeys. Specifically, study participants suggested that the impacts may be addressed by: having support from a professional to coordinate care, changing the approach of clinics and appointments (where they take place, which professionals/services are available and how they are scheduled), and improving communication through the use of technology, care plans, accessible points of contact and multi-disciplinary team working. Conclusion: This study provides further evidence of impacts of uncoordinated care; these may be complex and influenced by a number of factors. Approaches to coordination which improve access to care and lessen the time and burden placed on patients and carers may be particularly beneficial. Findings should influence future service developments (and the evaluation of such developments). This will be achieved, in the first instance, by informing the CONCORD Study in the UK.

1 April 2020 in International Journal of Integrated Care
Verified
Journal Article
Open access
PDF file
HWHolly Walton
Holly Walton
EHEmma Hudson
Emma Hudson
ASAmy Simpson
Amy Simpson
ARAngus I. G. Ramsay
Angus I. G. Ramsay
JKJoe Kai
Joe Kai
NFNaomi J. Fulop
Naomi J. Fulop
To coordinate care effectively for rare conditions, we need to understand what coordinated care means. This review aimed to define coordinated care and identify components of coordinated care within the context of rare diseases; by drawing on evidence from chronic conditions. A systematic scoping review. We included reviews that reported or defined and outlined components of coordinated care for chronic or rare conditions. Thematic analysis was used to develop a definition and identify components or care coordination. Stakeholder consultations (three focus groups with patients, carers and healthcare professionals with experience of rare conditions) were held to further explore the relevance of review findings for rare conditions. We included 154 reviews (n = 139 specific to common chronic conditions, n = 3 specific to rare conditions, n = 12 both common/rare conditions). A definition of coordination was developed. Components were identified and categorised by those that: may need to be coordinated, inform how to coordinate care, have multiple roles, or that contextualise coordination. Coordinated care is multi-faceted and has both generic and context-specific components. Findings outline many ways in which care may be coordinated for both rare and common chronic conditions. Findings can help to develop and eventually test different ways of coordinating care for people with rare and common chronic conditions.

1 September 2019 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
LYLauren Yates
Lauren Yates
ECEmese Csipke
Emese Csipke
EMEsmé D. Moniz-Cook
Esmé D. Moniz-Cook
PLPhuong Leung
Phuong Leung
HWHolly Walton
Holly Walton
MOMARTIN ORRELL
MARTIN ORRELL
Objective: Support after a diagnosis of dementia may facilitate better adjustment and ongoing management of symptoms. The aim of the Promoting Independence in Dementia (PRIDE) study was to develop a postdiagnostic social intervention to help people live as well and as independently as possible. The intervention facilitates engagement in evidence-based stimulating cognitive, physical and social activities. Methods: Theories to promote adjustment to a dementia diagnosis, including theories of social learning and self-efficacy, were reviewed alongside self-management and the selective optimization model, to form the basis of the intervention. Analyses of two longitudinal databases of older adults, and qualitative analyses of interviews of older people, people with dementia, and their carers about their experiences of dementia, informed the content and focus of the intervention. Consensus expert review involving stakeholders was conducted to synthesize key components. Participants were sourced from the British NHS, voluntary services, and patient and public involvement groups. A tailored manual-based intervention was developed with the aim for this to be delivered by an intervention provider. Results: Evidence-based stimulating cognitive, physical, and social activities that have been shown to benefit people were key components of the proposed PRIDE intervention. Thirty-two participants including people with dementia (n=4), carers (n=11), dementia advisers (n=14), and older people (n=3) provided feedback on the drafts of the intervention and manual. Seven topics for activities were included (eg, “making decisions” and “getting your message across”). The manual outlines delivery of the intervention over three sessions where personalized profiles and plans for up to three activities are developed, implemented, and reviewed. Conclusion: A manualized intervention was constructed based on robust methodology and found to be acceptable to participants. Consultations with stakeholders played a key role in shaping the manualized PRIDE intervention and its delivery. Unlike most social interventions for dementia, the target audience for our intervention is the people with dementia themselves.